Combinatorial strategies for combating invasive fungal infections
Related Experiment Video
Updated: Mar 19, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Michaela Spitzer1, Nicole Robbins1, Gerard D Wright1
1a Michael G. DeGroote Institute for Infectious Disease Research and the Department of Biochemistry and Biomedical Sciences , McMaster University , Hamilton , ON , Canada.
Abstract:
Invasive fungal infections are an important cause of human mortality and morbidity, particularly for immunocompromised populations. However, there remains a paucity of antifungal drug treatments available to combat these fungal pathogens. Further, antifungal compounds are plagued with problems such as host toxicity, fungistatic activity, and the emergence of drug resistance in pathogen populations. A promising therapeutic strategy to increase drug effectiveness and mitigate the emergence of drug resistance is through the use of combination drug therapy. In this review we describe the current arsenal of antifungals in medicine and elaborate on the benefits of combination therapy to expand our current antifungal drug repertoire. We examine those antifungal combinations that have shown potential against fungal pathogens and discuss strategies being employed to discover novel combination therapeutics, in particular combining antifungal agents with non-antifungal bioactive compounds. The findings summarized in this review highlight the promise of combinatorial strategies in combatting invasive mycoses.
Insights
Combination antifungal drug therapy offers a promising strategy to combat invasive fungal infections, addressing limitations like host toxicity and drug resistance. This approach expands treatment options for immunocompromised patients.
Area of Science:
- Mycology
- Pharmacology
- Infectious Diseases
Background:
- Invasive fungal infections pose significant mortality and morbidity risks, especially in immunocompromised individuals.
- Existing antifungal drugs face challenges including host toxicity, limited fungicidal activity, and emerging drug resistance.
- A limited number of antifungal treatments are currently available.
Purpose of the Study:
- To review the current landscape of antifungal drugs.
- To elaborate on the benefits of combination antifungal therapy.
- To explore novel combination strategies, including non-antifungal bioactive compounds.
Main Methods:
- Literature review of existing antifungal agents.
- Analysis of current combination antifungal therapies.
- Discussion of strategies for discovering new combination therapeutics.
Main Results:
- Combination therapy can enhance drug effectiveness and mitigate antifungal resistance.
- Several antifungal combinations demonstrate potential against pathogenic fungi.
- Combining antifungal agents with non-antifungal compounds is a promising discovery strategy.
Conclusions:
- Combinatorial strategies hold significant promise for treating invasive fungal infections.
- Expanding the antifungal drug repertoire through combinations is crucial.
- Further research into novel combination therapeutics is warranted.
Related Concept Videos
Antifungal Agents
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Anthelminthic Agents
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Clinical Significance of Antibiotic Resistance

